Inso Biosciences is simplifying DNA sample preparation to unlock access to genomics.
While DNA sequencing has advanced rapidly, front-end sample preparation has stagnated on outdated technologies with complex workflows and expensive automation requirements, limiting the accessibility and scale of genomic impacts.
Inso Biosciences has developed the world’s first binding-free approach for preparing DNA, utilizing microfluidic technologies invented at Cornell University. Our innovative product overcomes the limitations of traditional bead and column approaches, enabling affordable automation with faster turnaround, higher efficiency, better purity, and longer DNA, all in one compact benchtop instrument with no setup costs.
Our unique technology-driven capabilities are well suited for even challenging DNA, such as High Molecular Weight (HMW) samples used in ‘Long Read’ sequencing applications. Reach out us to learn more.
Together, we aim to empower the coming genomics revolution, where going from sample to answer is completed by just the push of a button.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Ithaca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.inso.bio
- Keywords
- Kelburn.
- HQ
- Ithaca
Inso Biosciences Questions
Inso Biosciences's website is http://www.inso.bio
Inso Biosciences's LinkedIn profile is https://www.linkedin.com/company/insobio
Inso Biosciences has
5 employees.
View email and phone details for 5
employees at Inso Biosciences.
Inso Biosciences's industry is
Biotechnology Research
Inso Biosciences's top competitors are
Amplified Sciences, Inc.,
Chemt Biotechnology,
Novilytic,
Brightest Bio,
Advemto Ltd.,
Full Circles Therapeutics Inc.,
Cho Plus, Inc.,
Amptiv Biosciences,
Osem Fluidics,
Evoworks Bio.
Inso Biosciences's categories are Biotechnology Research
Inso Biosciences's founding year is 2020
